Navigation Links
GeneGo's ToxHunter™ Suite of Tools and Content for Systems Toxicology Research Is Now Available
Date:7/13/2010

ST. JOSEPH, Mich., July 13 /PRNewswire/ -- GeneGo announced the availability of ToxHunter™, the first commercial release of tools and content developed through its industry-FDA MetaTox™ partnership program, a collaborative program developing a unique comprehensive systems toxicology suite designed for compound safety assessment in chemical and pharmaceutical R&D.

ToxHunter is now available as an add-on to existing licenses of GeneGo's MetaCore™ and/or MetaDrug™ systems biology and systems pharmacology platforms.

ToxHunter includes a unique, detailed ontology of compound-induced pathological observations covering 8 target organs in the initial release. This ontology is populated with a comprehensive, manually-curated knowledgebase of toxicant associations to pathology terms along with gene, protein, metabolite biomarkers of chemical toxicity. Content is searchable by pathology, toxicant, or gene, protein & metabolite biomarkers. ToxHunter enables new experimental analysis and visualization tools such as an exclusive enrichment module for identifying specific gene-pathology associations, a suite of new toxicity-focused pathway maps and QSAR models, and the ability to overlay toxicity biomarker information on maps and interaction networks.

"We are excited to provide this unique and powerful set of tools to better support our customers in safety assessment, who are making increased use of existing knowledge in concert with their own molecular data, in a systems approach to understand and predict adverse outcomes of chemical exposure," said Richard Brennan, Director Toxicology. "We will expand the capabilities of the platform in regular future updates, as more of the tools developed by the partnership are released."

"Our toxicology customers recognize the value of ToxHunter to their research," said Julie Bryant, VP Business Development. "The enthusiastic responses to demonstrations of pre-release versions, and strong pre-release sales to government, academic, clinical, and commercial customers validate the partnership program's ability to deliver tools and content with value in the marketplace." Numerous organizations, including Merck-Serono, The Hamner Institutes for Health Sciences, and the National Toxicology Program of the NIEHS have already licensed ToxHunter under GeneGo's pre-sale program.

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery™ platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 6.3™, assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 6.3™ is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase™ represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.

ToxHunter™, MetaCore™, MetaBase™ and MetaDrug™ are trademarks of GeneGo, Inc.


'/>"/>
SOURCE GeneGo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite
2. Sigma(R) Life Science Introduces Worlds First Suite of Knockout Rats for ADME/Tox Applications
3. Greenway Medical Technologies PrimeSuite Wins Three Best in KLAS Awards
4. Greenway Medical Technologies PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification
5. Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite
6. Rogan-Delft Approves Matrox Xenia Series for Use With Zillion Suite
7. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
8. SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
9. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
10. AdMeTech to Testify in Congress About Prostate Cancer Crisis, Research to Improve Diagnostic Tools as a Solution
11. InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 2017  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. ... of directors: Christopher Gabrieli ... serve as chairman of the board of Akcea Therapeutics. ... of Forest Laboratories. Sandford D. Smith ... "We are excited to announce this expansion to ...
(Date:3/28/2017)... , March 28, 2017 ... expected to reach a value of USD 4.5 billion ... View Research, Inc. Proper closure of injured tissues post ... and function. Postoperative leakages occur in 3% to 15% ... They are responsible for one third of postoperative deaths ...
(Date:3/27/2017)... , March 27, 2017 The National ... health and data analytics company, signed a Memorandum ... improving healthcare delivery in the region. ... Global Health Research and Technology (BIGHEART) at NUS ... several topics related to healthcare IT and medical ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... City trips ... (IBT World Travel Trends Report). As travelers visit both urban destinations, they are ... and prolonged sun exposure. In response, the outdoor industry has blurred the lines ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
(Date:3/28/2017)... Calif. (PRWEB) , ... March 28, 2017 , ... ... its leading physicians, Paul Yost, will begin serving as new board chair for ... this month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon and well-known ... to offer the recently FDA-approved Obalon Balloon System to his patients. The Obalon ... Surgical’s already comprehensive list of weight-loss services. Dr. Liu is proud to ...
Breaking Medicine News(10 mins):